Diverse effects of heparin on mitogen-activated protein kinase-dependent signal transduction in vascular smooth muscle cells

Circulation Research

Volumn 81, Issue 1, 1997, Pages 17-23

  Daum, Günter ^a   Hedin, Ulf ^a   Wang, Yunxia ^a   Wang, Trevina ^a   Clowes, Alexander W ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Heparin; Mitogen activated protein kinase; Proliferation; Restenosis

Indexed keywords

GLYCOSAMINOGLYCAN; HEPARIN; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE C;

ANGIOPLASTY; ANIMAL CELL; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BABOON; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; VASCULAR SMOOTH MUSCLE;

EID: 0030970720     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.1.17     Document Type: Article

References (46)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Schwartz SM, deBlois D, Brien ERM. The intima: soil for atherosclerosis and restenosis. Circ Res. 1995;77:445-465.
3. Letourneur D, Caleb BL, Castellot JJ Jr. Heparin binding, internalization, and metabolism in vascular smooth muscle cells, II: degradation and secretion in sensitive and resistant cells. J Cell Physiol. 1995;165:687-695.
4. Letourneur D, Caleb BL, Castellot JJ Jr. Heparin binding, internalization, and metabolism in vascular smooth muscle cells, I: upregulation of heparin binding correlates with antiproliferative activity. J Cell Physiol. 1995;165:676-686.
5. Clowes AW, Karnovsky MJ. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature. 1977;265: 625-626.
6. Geary RL, Koyama N, Wang TW, Vergel S, Clowes AW. Failure of hoparin to inhibit intimal hyperplasia in injured baboon arteries: the role of heparin-sensilive and -insensitive pathways in the stimulation of smooth muscle cell migration and proliferation. Circulation. 1995;91:2972-2981.
7. Nikkari ST, Jarvelainen HT, Wight TN, Ferguson M, Clowes AW. Smooth muscle cell expression of extracellular matrix genes after arterial injury. Am J Pathol. 1994;144:1348-1356.
8. Snow AD, Bolender RP, Wight TN, Clowes AW. Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells. Am J Pathol. 1990;137: 313-330.
9. Au YP, Kenagy RD, Clowes MM, Clowes AW. Mechanisms of inhibition by heparin of vascular smooth muscle cell proliferation and migration. Haemostasis. 1993;1:177-182.
10. Kenagy RD, Nikkari ST, Welgus HG, Clowes AW. Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells. J Clin Invest. 1994;93:1987-1993.
11. Kenagy RD, Clowes AW. Regulation of baboon arterial smooth muscle cell plasminogen activators by heparin and growth factors. Thromb Res. 1995;77-55-61.
12. Pukac LA, Castellot JJ Jr, Wright TC Jr, Caleb BL, Karnovsky MJ. Heparin inhibits c-fos and c-mye mRNA expression in vascular smooth muscle cells. Cell Regul. 1990;1:435-443.
13. Busch SJ, Martin GA, Barnhart RL, Mano M, Cardin AD, Jackson RL. Trans-repressor activity of nuclear glycosaminoglycans on Fos and Jun/AP-1 oncoprotein-mediated transcription. J Cell Biol. 1992;116:31-42.
14. Au YPT, Dobrowolska G, Morris DR, Clowes AW. Heparin decreases activator protein-1 binding to DNA in part by posttranslational modification of Jun B. Circ Res. 1994;75:15-22.
15. Ottlinger ME, Pukac LA, Karnovsky MJ. Heparin inhibits mitogen-activated protein kinase activation in intact rat vascular smooth muscle cells. J Biol Chem. 1993;268:19173-19176.
16. mapk are required for fibroblast proliferation. Proc Natl Acad Sci U S A. 1993;90:8319-8323.
17. Cano E, Mahadevan LC. Parallel signal processing among mammalian MAPKs. Trends Biochem Sci. 1995;20:117-122.
18. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J. 1995;9:726-735.
19. Zheng CF, Guan KL. Activation of MEK family kinases requires phosphorylation of two conserved Ser/Thr residues. EMRO J. 1994;13:1123-1131.
20. Alessi DR, Saito Y, Campbell DG, Cohen P, Sithanandam G, Rapp UR, Ashworth A, Marshall CJ, Cowley S. Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. EMBO J. 1994;13:1610-1619.
21. Leevers SJ, Paterson HF, Marshall CJ. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature. 1994;369:411-414.
22. Stotoe D, Macdonald SG, Cadwallader K, Symons M, Hancock JF. Activation of Raf as a result of recruitment to the plasma membrane. Science. 1994;264:1463-1467.
23. Daum G, Eisenmann-Tappe I, Fries HW, Troppmair J, Rapp UR. The ins and outs of Raf kinases. Trends Biochem Sci. 1994;19: 474-480.
24. van Corven EJ, Hordijk PL, Medema RH, Bos JL, Moolenaar WH. Pertussis toxin-sensitive activation of p21ras by G protein-coupled receptor agonists in fibroblasts. Proc Natl Acad Sci U S A. 1993;90: 1257-1261.
25. Crespo P, Xu N, Simonds WF, Gutkind JS. Ras-dependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits. Nature. 1994;369:418-420.
26. Seger R, Seger D, Reszka AA., Munar ES, Eldar-Finkelman H, Dobrowolska G, Jensen AM, Campbell JS, Fischer EH, Krebs EG. Overexpression of mitogen-activated protein kinase kinase (MAPKK) and its mutants in NIH 3T3 cells: evidence that MAPKK involvement in cellular proliferation is regulated by phosphorylation of serine residues in its kinase subdomains VII and VIII. J Biol Chem. 1994;269:25699-25709.
27. Deibler GE, Martenson RE, Kies MW. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep Biochem. 1972;2:139-165.
28. Robbins DJ, Zhen E, Owaki H, Vanderbilt CA, Ebert D, Geppert TD, Cobb MH. Regulation and properties of extracellular signalregulated protein kinases 1 and 2 in vitro. J Biol Chem. 1993;268: 5097-5106.
29. Ross R, Kariya B. Morphogenesis of vascular smooth muscle cells in atherosclerosis and cell culture. In: Bohr D, ed. Handbook of Physiology, Section 2: The Cardiovascular System, Volume II. Bethesda, Md: American Physiological Society; 1980:69-91.
30. Gotoh Y, Nishida E, Yamashita T, Hoshi M, Kawakami M, Sakai H. Microtubule-associated-protein (MAP) kinase activated by nerve growth factor and epidermal growth factor in PC12 cells: identity with the mitogen-activated MAP kinase of fibroblastic cells. Eur J Biochem. 1990;193:661-669.
31. Kameshita I, Fujisawa H. A sensitive method for detection of calmodulin-dependent protein kinase II activity in sodium dodecyl sulfate-polyacrylamide gel. Anal Biochem. 1989;183:139-143.
32. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
33. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
34. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76: 4350-4354.
35. Boulton TG, Cobb M. Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies. Cell Regul. 1991;2:357-371.
36. Downey GP, Butler JR, Brumell J, Borregaard N, Kjeldsen L, Sue A, Quan AK, Grinstein S. Chemotactic peptide-induced activation of MEK-2, the predominant isoform in human neutrophils: inhibition by wortmannin. J Biol Chem. 1996;271:21005-21011.
37. Zhao Z, Tan Z, Diltz CD, You M, Fischer EH. Activation of mitogen-activated protein (MAP) kinase pathway by pervanadate, a potent inhibitor of tyrosine phosphatases. J Biol Chem, 1996;271: 22251-22255.
38. Pukac LA, Ottlinger ME, Karnovsky MJ. Heparin suppresses specific second messenger pathways for protooncogene expression in rat vascular smooth muscle cells. J Biol Chem. 1992;267: 3707-3711.
39. Herbert JM, Clowes M, Lea H, Pascal M, Clowes AW. Protein kinase C α expression is required for heparin inhibition of rat smooth muscle cell proliferation in vitro and in vivo. J Biol Chem. 1996;271:25928-25935.
40. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marmé D, Schachtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J Biol Chem. 1993;268:9194-9197.
41. Venkataraman G, Sasisekharan V, Herr AB, Ornitz DM, Waksman G, Cooney CL, Langer R, Sasisekharan R. Preferential selfassociation of basic fibroblast growth factor is stabilized by heparin during receptor dimerization and activation. Proc Natl Acad Sci U S A. 1996;93:845-850.
42. Choi KY, Satterberg B, Lyons DM, Elion EA. Ste5 tethers multiple protein kinases in the MAP kinase cascade required for mating in S. cerevisiae. Cell. 1994;78:499-512.
43. Jelinek T, Catling AD, Reuter CW, Moodie SA, Wolfman A, Weber MJ. Ras and Raf-1 form a signalling complex with MEK-1 but not MEK-2. Mol Cell Biol. 1994;14:8212-8218.
44. Liao D-F, Duff JL, Daum G, Pelech SL, Berk BC. Angiotensin II stimulates MAP kinase kinase kinase activity in vascular smooth muscle cells: role of Raf. Circ Res. 1996;79:1007-1014.
45. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D, Kirilovsky J. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem. 1991;206:15771-15781.
46. ++ dependent protein kinase. Biochem Biophys Res Commun. 1986;135:397-402.